Here, a decrease in markers such as CD25 and OX40 after CPM, suggest that the Tregs remaining within the tumor could have reduced suppressor function compared to NT tumor Tregs (Fontenot et al., 2003; Willoughby et al., 2017). This evidence concerns the gene TNFRSF4 and neoplasm.